Disc Medicine, a clinical-stage biopharmaceutical company, announced the pricing of an upsized public offering of 6 million common shares at $75 each, raising approximately $450 million before expenses. The proceeds will support research, clinical development, and commercialization efforts for its treatments targeting serious hematologic diseases, including bitopertin for erythropoietic protoporphyria. The offering is expected to close on October 22, 2026, with underwriters having an option to buy additional shares. This capital raise aims to advance Disc's pipeline and general corporate purposes.
Disc Medicine's recent $450 million stock offering provides context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 21, 2026 08:02 WIB: out of 150 priced US health-sector stocks, 132 rose and 18 fell. Among notable movers, RVMD rose 7.91% to USD 196.55 with a typical hold time of 5 days, MRNA increased 7.65% to USD 244.24 with a 40% sell and 60% buy order split and a 59-day hold time, while AMWL gained 7.46% to USD 13.25 with a 62-day typical hold time.
HUTCHMED has finalized an exclusive license agreement with GSK granting GSK rights to develop and commercialize HMPL-A830, a novel KRAS-EGFR antibody conjugate therapy, outside China, Hong Kong, Macau, and Taiwan. This therapy targets cancers with KR...
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Between Sept. 19 and Oct. 18, 2026, nearly all Ripple USD (RLUSD) payments on the XRP Ledger were tiny transfers under one unit, totaling about 7.8 million payments. These small transfers mainly came from 110 wallets sending tiny amounts to three rec...
Bitcoin's options implied volatility, measured by Deribit's DVOL index, stood at 38.28% annualized on October 20, significantly higher than the realized volatility of around 20-25% based on recent price movements. This difference reflects the forward...
Bitcoin (BTC) remained stuck below the $87,000 to $87,800 resistance range during a period of narrow trading and low volume. There is a potential supply zone near $90,000, which sits above the current resistance band. The cryptocurrency has not manag...
